DBV Technologies (DBVT) FCF Margin (2014 - 2026)
DBV Technologies (DBVT) reported FCF Margin of 5500.0% for Q1 2026, down 303750.0% year-over-year from N/an in Q1 2025, and little changed on a QoQ basis from 5511.01% in Q4 2025.
DBV Technologies (DBVT) has 11 years of FCF Margin data on file, last reported at 5500.0% in Q1 2026.
- Quarterly FCF Margin fell 303750.0% year-over-year to 5500.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2619.52% (down 6633.0% YoY) and the FY2025 annual result came in at 2159.56%, up 41360.0% from the prior year.
- FCF Margin was little changed at 5500.0% in Q1 2026 per DBVT's latest filing, from 5511.01% in the prior quarter.
- Across five years, FCF Margin topped out at 1832.59% in Q4 2022 and bottomed at 5511.01% in Q4 2025.
- The 5-year median for FCF Margin is 1173.47% (2025), against an average of 1769.25%.
- The widest annual swing landed in 2022, when FCF Margin surged 250449 bps; it then plunged 313782 bps in 2025.
- Tracing DBVT's FCF Margin over 5 years: stood at 1832.59% in 2022, then plunged by 109 bps to 158.17% in 2023, then plunged by 1400 bps to 2373.19% in 2024, then tumbled by 132 bps to 5511.01% in 2025, then rose by 0 bps to 5500.0% in 2026.
- Per Business Quant, the three latest DBVT FCF Margin figures stand at 5500.0% (Q1 2026), 5511.01% (Q4 2025), and 1173.47% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -5,500.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,500.00% |
| Dec 31, 2025 | -5,511.01% |
| Sep 30, 2025 | -1,173.47% |
| Jun 30, 2025 | -2,315.02% |
| Mar 31, 2025 | -2,462.50% |
| Dec 31, 2024 | -2,373.19% |
| Sep 30, 2024 | -2,131.81% |
| Jun 30, 2024 | -3,083.98% |
| Mar 31, 2024 | -2,560.55% |
| Dec 31, 2023 | -158.17% |
| Sep 30, 2023 | -827.28% |
| Jun 30, 2023 | -1,123.99% |
| Mar 31, 2023 | -954.97% |
| Dec 31, 2022 | 1,832.59% |
| Sep 30, 2022 | -984.62% |
| Jun 30, 2022 | -685.94% |
| Mar 31, 2022 | -63.39% |
| Dec 31, 2021 | -671.90% |
| Sep 30, 2021 | -1,733.64% |
| Jun 30, 2021 | -2,024.73% |
| Mar 31, 2021 | -1,237.27% |
| Dec 31, 2020 | 2,766.58% |
| Sep 30, 2020 | -1,015.58% |
| Mar 31, 2020 | -1,069.89% |
| Sep 30, 2019 | -1,056.10% |
| Dec 31, 2018 | 1,285.67% |
| Sep 30, 2018 | -3,435.84% |
| Dec 31, 2015 | -392.46% |
| Dec 31, 2014 | -393.61% |